{"title":"[The mind without images : aphantasia and autism spectrum disorder, an invisible connection.]","authors":"Hedi Klila, Fabienne Giuliani","doi":"10.53738/REVMED.2025.21.911.618","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.911.618","url":null,"abstract":"<p><p>For people with aphantasia, the ability to form mental images is absent or markedly impaired. In this article, we define aphantasia and explore the links between mental imagery and autism spectrum disorder. Through our clinical experiences, we highlight the repercussions the impact of aphantasia on autism spectrum disorder functioning, share the specific challenges we face in psychotherapy and propose therapeutic approaches.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 911","pages":"618-621"},"PeriodicalIF":0.0,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Rhinoshave technique using a disposable razor with a fixed head].","authors":"Michael Mühlstädt, Jöri Pünchera","doi":"10.53738/REVMED.2025.21.911.599","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.911.599","url":null,"abstract":"<p><p>Rhinophyma is a severe form of rosacea that leads to unsightly thickening and progressive deformation of the nose. Beyond the physical symptoms, such as respiratory discomfort in extreme cases, rhinophyma is primarily marked by strong social stigma. The red, bulbous appearance of the nose, often associated in literature and art with stereotypes related to alcoholism, perpetuates unfounded prejudices. This misconception can cause embarrassment in affected patients, diminishing their self-confidence and sometimes leading to social isolation. The treatment of rhinophyma mainly relies on ablative interventional methods aimed at reducing excess tissue. This article examines the rhinoshave technique using a disposable razor with a fixed head, detailing its advantages and risks.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 911","pages":"599-601"},"PeriodicalIF":0.0,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Urgences saturées : un hiver de plus.","authors":"Thomas Schmutz, Vincent Ribordy","doi":"10.53738/REVMED.2025.21.911.636","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.911.636","url":null,"abstract":"","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 911","pages":"636"},"PeriodicalIF":0.0,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Inhibiteurs de JAK: pour les effets secondaires, veuillez consulter la FDA ?","authors":"Wolf-Henning Boehncke, Michel Gilliet","doi":"10.53738/REVMED.2025.21.911.579","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.911.579","url":null,"abstract":"","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 911","pages":"579-580"},"PeriodicalIF":0.0,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gabriel Hans, Benedek Roska, Mallory Moret Bochatay
{"title":"[Antibiotic prophylaxis when taking corticosteroids].","authors":"Gabriel Hans, Benedek Roska, Mallory Moret Bochatay","doi":"10.53738/REVMED.2025.21.911.628","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.911.628","url":null,"abstract":"<p><p>Antibioprophylaxis in the setting of high-dose corticosteroid therapy is primarily indicated for the prevention of Pneumocystis jirovecii pneumonia (PJP), a potentially fatal infection in immunocompromised individuals. According to the American Thoracic Society (2010) and National Comprehensive Cancer Network (NCCN) guidelines (2024), prophylactic administration of co-trimoxazole is recommended only for patients who are immunocompromised and receiving corticosteroid therapy at doses ≥20 mg of prednisone equivalent per day for ≥28 days. Deviation from these guidelines may unnecessarily expose patients to serious and potentially life-threatening adverse effects of co-trimoxazole, such as agranulocytosis.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 911","pages":"628-629"},"PeriodicalIF":0.0,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Hot Topics 2024 and 2025 in dermatology].","authors":"David Alvarez Martinez, Gürkan Kaya","doi":"10.53738/REVMED.2025.21.911.606","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.911.606","url":null,"abstract":"<p><p>Dermatology has made significant advances in recent years. Ruxolitinib cream offers new hope for vitiligo, though reimbursement remains uncertain. A consensus now standardizes the management of Drug Reaction with Eosinophilia and Systemic Symptoms, while IL-26 emerges as a promising target in pustular psoriasis. Concerns about a potential link between dupilumab and cutaneous T-cell lymphoma call for increased clinical vigilance. Meanwhile, bimekizumab marks a breakthrough in hidradenitis suppurativa treatment. Addressing Trichophyton indotineae resistance requires complex strategies. Finally, innovative laser targeting sebaceous glands offers new hope for acne.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 911","pages":"606-610"},"PeriodicalIF":0.0,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Acquired erythroderma in adults].","authors":"Premila Kamler, Begonia Cortés","doi":"10.53738/REVMED.2025.21.911.582","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.911.582","url":null,"abstract":"<p><p>Erythroderma is a serious dermatological syndrome characterized by prolonged erythema and scaling, affecting more than 80 % of the body surface. Erythroderma can have multiple etiologies, the most common of which are grouped under the acronym PALM (psoriasis, atopic dermatitis, lymphoproliferative disorders, and medications). Nevertheless, the clinical presentation is similar regardless of the cause. In this article, we will discuss the most common causes of acquired erythroderma in adults, the diagnostic approach, and treatment management, although the latter strongly depends on its etiology.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 911","pages":"582-586"},"PeriodicalIF":0.0,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}